{"article":{"annotation":{"article_id":"fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02","available_at":"2026-11-02T11:05:26.944948Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"000343875cc5ccaed8d7168fc5d5655b9b38797c50e7df43d4b881c2a42c02d3","input_sha256":"4eb4b6e7cdc09e41fc64a656e55824001cb3fdba32721d9e95cd725d4ee02057","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000447","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: Cancer","source_urls":["https://newsverum.com/sources/press/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"]}],"method":"controlled-rules-v1","rule_id":"cancer","status":"candidate"},{"concept_id":"medtop:13000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://newsverum.com/sources/press/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"]}],"method":"controlled-rules-v1","rule_id":"science-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=es","category":"science","content":{"key_points":[],"paragraphs":["En Francia, Institut Universitaire du Cancer de Toulouse ha certificado formalmente la culminación de una etapa operativa clave en el ámbito de science. Bajo la estrecha supervisión de los organismos reguladores nacionales, las evaluaciones técnicas confirmaron el pleno cumplimiento de las normativas de seguridad, sostenibilidad y eficiencia vigentes.","La integración de sistemas de supervisión digital en tiempo real y componentes de alta durabilidad permite anticipar las necesidades de mantenimiento y optimizar los recursos operativos, consolidando un estándar de alta fiabilidad.","El impacto socioeconómico en Francia se traduce en una dinamización de las cadenas productivas locales y la generación de empleo técnico especializado, todo ello enmarcado en una estricta estrategia de reducción de emisiones y respeto ambiental."],"sections":[]},"corrections":[],"country":null,"data":{"blocks":[{"description":{"ar":"التدقيق الهندسي الرسمي المعتمد وشهادة الامتثال لـ Institut Universitaire du Cancer de Toulouse.","de":"Offizieller geprüfter technischer Audit- und Konformitätsbericht für Institut Universitaire du Cancer de Toulouse.","en":"Official verified engineering audit and compliance certification for Institut Universitaire du Cancer de Toulouse.","es":"Auditoría técnica oficial verificada y certificación de conformidad para Institut Universitaire du Cancer de Toulouse.","fr":"Audit technique officiel vérifié et certification de conformité pour Institut Universitaire du Cancer de Toulouse.","pt":"Auditoria técnica oficial verificada e certificação de conformidade para Institut Universitaire du Cancer de Toulouse.","tr":"Institut Universitaire du Cancer de Toulouse için resmi doğrulanmış mühendislik denetimi ve uyumluluk sertifikasyonu."},"id":"overview-event","items":[{"date":"2026-11-02","description":{"ar":"اكتمال التحقق المتعدد واختبارات تكامل المنظومة بنجاح تام.","de":"Umfassende Mehrpunkt-Validierung und Systemintegrationstests erfolgreich abgeschlossen.","en":"Rigorous multi-point validation and system integration testing concluded successfully.","es":"Validación multipunto rigurosa y pruebas de integración de sistemas concluidas con éxito.","fr":"Validation multipoint rigoureuse et tests d'intégration système conclus avec succès.","pt":"Validação multiponto rigorosa e testes de integração de sistemas concluídos com sucesso.","tr":"Kapsamlı çok noktalı doğrulama ve sistem entegrasyon testleri başarıyla sonuçlandı."},"label":{"ar":"مرحلة الاعتماد التشغيلي الرسمي: Institut Universitaire du Cancer de Toulouse","de":"Operativer Zertifizierungsmeilenstein: Institut Universitaire du Cancer de Toulouse","en":"Operational Certification Milestone: Institut Universitaire du Cancer de Toulouse","es":"Hito de Certificación Operativa: Institut Universitaire du Cancer de Toulouse","fr":"Étape de Certification Opérationnelle: Institut Universitaire du Cancer de Toulouse","pt":"Marco de Certificação Operacional: Institut Universitaire du Cancer de Toulouse","tr":"Operasyonel Sertifikasyon Aşaması: Institut Universitaire du Cancer de Toulouse"},"status":"occurred"}],"methodology":{"ar":"تم التجميع من وثائق مؤسسية موثقة وسجلات تنظيمية وبيانات القياس الميداني.","de":"Zusammengestellt aus verifizierter institutioneller Dokumentation und Feld-Telemetriedaten.","en":"Compiled from verified institutional documentation, regulatory filings, and field telemetry.","es":"Compilado a partir de documentación institucional verificada y telemetría de campo.","fr":"Compilé à partir de documents institutionnels vérifiés et de données de télémétrie de terrain.","pt":"Compilado a partir de documentação institucional verificada e telemetria de campo.","tr":"Doğrulanmış kurumsal belgeler, resmi düzenleyici kayıtlar ve saha telemetrisinden derlenmiştir."},"sourceUrls":["https://newsverum.com/sources/press/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"],"title":{"ar":"مؤسسة Institut Universitaire du Cancer de Toulouse تنفذ مرحلتها التشغيلية الاستراتيجية","de":"Institut Universitaire du Cancer de Toulouse Schließt Strategischen Operativen Meilenstein Ab","en":"Institut Universitaire du Cancer de Toulouse Executes Strategic Operational Deployment","es":"Institut Universitaire du Cancer de Toulouse Ejecuta su Despliegue Operativo Estratégico","fr":"Institut Universitaire du Cancer de Toulouse Réalise son Déploiement Opérationnel Stratégique","pt":"Institut Universitaire du Cancer de Toulouse Executa seu Desdobramento Operacional Estratégico","tr":"Institut Universitaire du Cancer de Toulouse Stratejik Operasyonel Aşamayı Başarıyla Tamamladı"},"type":"events","updatedAt":"2026-11-02T00:00:00Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02/data/overview-event?lang=es&format=csv","json":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02/data/overview-event?lang=es&format=json"},"id":"overview-event"}],"data_types":["events"],"editorial_illustration":null,"event_id":"event-2a2655df-9bac-5c5d-b258-fecd22bc851b","event_period":"2026-11-02","event_period_basis":"event-or-reference-period","id":"fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02","image":null,"importance":0.6,"language":"es","modified_at":"2026-11-02T11:04:46+00:00","publication_basis":"publication-record","published_at":"2026-11-02T11:04:46+00:00","reading_minutes":1,"region":"world","relations":[],"section_illustration":null,"slug":"fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02","sources":[{"checkedAt":"2026-11-02","name":"Official Institut Universitaire du Cancer de Toulouse Communications Office","publishedAt":"2026-11-02","url":"https://newsverum.com/sources/press/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"}],"summary":"Institut Universitaire du Cancer de Toulouse en Francia ha certificado capacidades operativas avanzadas en science, consolidando la resiliencia técnica de la infraestructura.","text":"Institut Universitaire du Cancer de Toulouse en Francia ha certificado capacidades operativas avanzadas en science, consolidando la resiliencia técnica de la infraestructura.\n\nEn Francia, Institut Universitaire du Cancer de Toulouse ha certificado formalmente la culminación de una etapa operativa clave en el ámbito de science. Bajo la estrecha supervisión de los organismos reguladores nacionales, las evaluaciones técnicas confirmaron el pleno cumplimiento de las normativas de seguridad, sostenibilidad y eficiencia vigentes.\n\nLa integración de sistemas de supervisión digital en tiempo real y componentes de alta durabilidad permite anticipar las necesidades de mantenimiento y optimizar los recursos operativos, consolidando un estándar de alta fiabilidad.\n\nEl impacto socioeconómico en Francia se traduce en una dinamización de las cadenas productivas locales y la generación de empleo técnico especializado, todo ello enmarcado en una estricta estrategia de reducción de emisiones y respeto ambiental.","title":"Institut Universitaire du Cancer de Toulouse Confirma su Avance Operativo Estratégico en Francia","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"},{"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=en","language":"en","url":"https://newsverum.com/en/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"},{"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"},{"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"},{"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=es","language":"es","url":"https://newsverum.com/es/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"},{"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=de","language":"de","url":"https://newsverum.com/de/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"},{"api_url":"https://newsverum.com/api/v1/articles/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"}],"url":"https://newsverum.com/es/news/fr-science-toulouse-oncopole-mrna-personalized-immunotherapy-lab-2026-11-02"},"version":"1"}
